mobile menu
Diabetes in CVD: Strategies for diagnosis
29-Apr-16
Cosentino, MD, PhD F.
CVOTs in Diabetes
29-Apr-16
Schnell, Prof. O.
Differential treatment of diabetes in CVD
29-Apr-16
Ceriello, Prof. A.
Hypertension and diabetic complications
04-Dec-15
Standl, Prof. E.
Cardiovascular outcome studies and glucose-lowering therapies
03-Dec-15
Standl, Prof. E.
Diabetes and atherosclerosis: New insights from the bench to the clinic
03-Dec-15
Del Prato, Prof. S.
Hot topics in diabetes (Archive)
18-Sep-14
Weitgasser, Prof. R.
Protecting the periphery (Archive)
18-Sep-14
Skrha, Prof. J.
EASD/ESC Symposium: Hypertension and vascular ageing in the elderly (Archive)
16-Sep-14
Lalic, Prof. N.
Lecture of Awardee: CVD impacts on individual glycemic targets and therapy – knowns and unknowns (Archive)
05-Dec-13
Standl, Prof. E.
Introduction to the Award including commemoration of the late Prof. Harry Keen (Archive)
05-Dec-13
Zimmet, Prof. P.
Introducing the latest CV safety studies in type 2 diabetes (Archive)
23-Sep-13
Mannucci, Dr. E.
Key findings from the SAVOR study: the effects of saxagliptin (Archive)
23-Sep-13
Darius, Prof. Dr. H.
The potential impact of SAVOR on clinical practice (Archive)
23-Sep-13
Mathieu, Prof. Ch.
Summary (Archive)
23-Sep-13
Nauck, Prof. M. A.
How could we transform treatment in type 2 diabetes: which approach, when and for whom? (Archive)
23-Sep-13
Nauck, Prof. M. A. / Barnett, Prof. A. / Vilsboll, Dr. T. / Hadjadj, Dr. S. / Rossing, Dr. P. / Mannucci, Dr. E. / Darius, Prof. Dr. H. / Mathieu, Prof. Ch.
OSA and cardiovascular risk (Archive)
01-Oct-12
Barbé Illa, MD F.
Self-monitoring of blood glucose – to be or not to be in non-insulin treated patients (Archive)
27-Aug-12
Schnell, Prof. O.
Compensating for the effect of glycemic worsening drugs, e.g. statins (Archive)
27-Aug-12
Standl, Prof. E.
Blood glucose lowering drugs: old problems, new promises (Archive)
27-Aug-12
Rydén, Prof. L.
The need for individualized medicine in diabetes (Archive)
06-Dec-11
Ceriello, Prof. A.
Statin and RAAS inhibitor for every diabetic patient? (Archive)
06-Dec-11
Standl, Prof. E.
Patterns of continuous glucose monitoring: A role for prediction or cardiac arrhythmias? (Archive)
06-Dec-11
Hanefeld, Prof. M.
Self-monitoring of blood glucose: Impact on CV risk in diabetes (Archive)
06-Dec-11
Schnell, Prof. O.
Estimating individual CVD risk in Type 2 diabetes (Archive)
06-Dec-11
Holman, Prof. R.
Left ventricular dysfunction in diabetes (the DYDA Study) (Archive)
29-Oct-11
Comaschi, Prof. M.
CVD outcome studies in diabetes (Archive)
29-Oct-11
Standl, Prof. E.
Sleep-disordered breathing and cardio-metabolic disease (Archive)
29-Oct-11
Wilding, Prof. J.
Potentials for cardioprotection (Archive)
29-Oct-11
Marx, Prof. N.
Cardiac rehabilitation in diabetes (Archive)
28-Oct-11
Vergès, Prof. B.
Hypoglycemia as an aggravating factor of atherosclerosis (Archive)
28-Oct-11
Conget, Dr. I.
Genome-wide association data and CV risk (Archive)
28-Oct-11
Tuomilehto, Prof. J.
Silent diabetes and silent CAD: two sides of the same coin? (Archive)
28-Oct-11
Tschöpe, Prof. D.
Mitochondrial dysfunction and type 2 diabetes: pathways for cardiovascular complications (Archive)
28-Oct-11
Roden, Prof. M.
Molecular, neuronal and metabolic imaging of the diabetic heart (Archive)
28-Oct-11
Bengel, Prof. F. M.
Diabetic cardiac autonomic neuropathy: does it really matter? (Archive)
28-Oct-11
Valensi, Prof. P.
The future of treatment of hypertension in diabetes (Archive)
27-Oct-11
Kintscher, Prof. U.
Diabetes and CVD in China (Archive)
27-Oct-11
Ji, Prof. L.
Implementing "Structured Testing" of blood glucose in Italy: The PRISMA study (Archive)
12-Sep-11
Bosi, Prof. E.
Improving cardiovascular outcome by reducing glycemic variability and post-prandial glucose excursions (Archive)
12-Sep-11
Ceriello, Prof. A.
Going beyond conventional therapies: an update on DPP-4 inhibition (Archive)
12-Sep-11
Holst, Prof. J. J.
A Case Presentation on type 2 diabetes and coronary artery disease (Archive)
20-Sep-10
Schnell, Prof. O.
Type 2 Diabetes: Should it still be considered as an Equivalent of Coronary Heart Disease?! - YES - (Archive)
30-Jun-10
Standl, Prof. E.
Type 2 Diabetes: Should it still be considered as an Equivalent of Coronary Heart Disease?! - YES - Rebuttal (Archive)
30-Jun-10
Standl, Prof. E.
Hypoglycemia: The neglected complication? (Archive)
10-Apr-10
Schnell, Prof. O.
HbA1c for diagnosis of diabetes: What are we gaining, what are we loosing? (Archive)
10-Apr-10
Hanefeld, Prof. M.
Cardio-metabolic interactions and side effects of multifactorial risk management (Archive)
10-Apr-10
Standl, Prof. E.
CV benefits of GLP-1 analogues and DPP-IV inhibitors: Fact or myth? (Archive)
10-Apr-10
Tschöpe, Prof. D.
HbA1c for Diagnosis of Diabetes – What are we gaining, what are we losing? (Archive)
19-Oct-09
Zimmet, Prof. P.
Is HbA1c sufficient for the evaluation of hyperglycemia-related CVD risk in diabetes? (Archive)
19-Oct-09
Ceriello, Prof. A.
Hypoglycemia as a CV-risk factor (Archive)
19-Oct-09
Tuomilehto, Prof. J.
Postprandial hyperglycaemia as a driving force in diabetes and CVD (Archive)
18-Oct-09
Ceriello, Prof. A.
Glucose lowering interventions in diabetes and CVD - lessons from outcome studies (Archive)
18-Oct-09
Chiasson, Prof. J.-L.
Acarbose - safe and effective glycaemic control with cardiovascular benefits (Archive)
18-Oct-09
Josse, Prof. R.
Recent guideline recommendations for managing pre- and established diabetes and CVD (Archive)
18-Oct-09
Schnell, Prof. O.
The Acarbose Cardiovascular Evaluation (ACE) study - secondary prevention of CVD in prediabetes (Archive)
18-Oct-09
Holman, Prof. R.
Summary and conclusions (Archive)
18-Oct-09
Chiasson, Prof. J.-L.
Heart Failure in Diabetes (Archive)
29-Aug-08
Böhm, Prof. M.
Postpranial hyperclycaemia as a driving force in diabetes and CVD - epidemiological evidence & molecular insights (Archive)
01-Jun-08
Ceriello, Prof. A.
Two sides of the same coin - guideline recommendations for managing diabetes and CVD (Archive)
01-Jun-08
Rydén, Prof. L.
Screening and intervention programmes to prevent diabetes and CVD - an example from daily practice (Archive)
01-Jun-08
Satman, Prof. I.
Glycemic Control & CVD: What does the Evidence Show? What answers are on the Horizon? (Archive)
17-Oct-07
Gerstein, Prof. H. C.
Target Glycaemic Control: Two Experts` Perspectives (Archive)
17-Oct-07
Jellinger, Dr. P.
Our Children with Diabetes: Hearts at Risk (Archive)
27-Sep-07
Kaufman, MD F.
New Coaching Techniques (Archive)
18-Sep-07
Standl, Prof. E.
CVD Risk Reduction In Prediabetes - Impact of Recent Studies and of the ACARBOSE CARDIOVASCULAR EVALUATION (ACE) Trial (Archive)
17-Sep-07
Holman, Prof. R.
Managing Dysglycemia And CVD - Exploring Current Treatment Options (Archive)
17-Sep-07
Chiasson, Prof. J.-L.
Latin American Experience (Archive)
17-Sep-07
Rosas, Dr. J.
North American Experience (Archive)
17-Sep-07
Chiasson, Prof. J.-L.
Asian Experience (Archive)
17-Sep-07
Shaw, Dr. J.
European Experience (Archive)
17-Sep-07
Tuomilehto, Prof. J.
Management of cardiovascular disease: Coronary interventions (Archive)
29-Jun-07
Rydén, Prof. L.
Definition and classification of diabetes and pre-diabetic glucose abnormalities (Archive)
29-Jun-07
Bartnik, Dr. M.
Identification of subjects at high risk for cardiovascular disease or diabetes (Archive)
29-Jun-07
Tuomilehto, Prof. J.
Treatment to reduce cardiovascular risk: Life style counselling and glycemic control (Archive)
29-Jun-07
Standl, Prof. E.
Treatment to reduce cardiovascular risk: Hypertension and dyslipidemia (Archive)
29-Jun-07
Östergren, Prof. J.
Management of cardiovascular diseases: Acute coronary syndromes (Archive)
29-Jun-07
Malmberg, Prof. K.
Guideline distribution and adherence in a general perspective (Archive)
29-Jun-07
Vahanien, Prof. A.
Management of cardiovascular diseases: Peripheral and cerebrovascular disease (Archive)
29-Jun-07
Östergren, Prof. J.
Acarbose – a proven role in prediabetes and beyond (Archive)
03-Dec-06
Chiasson, Prof. J.-L.
CVD risk reduction in prediabetes – current and future outcome trials (Archive)
03-Dec-06
Holman, Prof. R.
Dysglycaemia and CVD – the deadly duo (Archive)
03-Dec-06
Rydén, Prof. L.
Halting disease progression – the need for early intervention (Archive)
03-Dec-06
Hu, Prof. D.
Glucobay® – treating dysglycaemia and reducing CVD risk (Archive)
03-Dec-06
Chiasson, Prof. J.-L.
A new outcome trial with Glucobay® – further investigation in diabetes and CVD prevention (Archive)
03-Dec-06
Holman, Prof. R.
Type 2 Diabetes and CVD - a tale of two diseases? (Archive)
05-Sep-04
Alberti, Prof. Sir G.
Acarbose - a first-line therapy to break the CVD connection (Archive)
05-Sep-04
Haffner, Prof. S.
The role of Aspirin™ for CV risk reduction in diabetes (Archive)
05-Sep-04
Armitage, Prof. J.
Nifedipine GITS - a time for ACTION in diabetes patients (Archive)
05-Sep-04
Ruilope, Prof. L.
Normalizing glucose metabolism along the diabetes continuum - benefits beyond metabolic control (Archive)
28-Aug-03
Hanefeld, Prof. M.
Chairman´s welcome and objectives (Archive)
28-Aug-03
Holman, Prof. R.
Reducing the risk of cardiovascular events in diabetes - evidence based options (Archive)
28-Aug-03
Josse, Prof. R.
Prevention of CV events in diabetics by antiplatelet therapy (Archive)
28-Aug-03
Karasik, Prof. A.